Cardiac Rehabilitation Expansion at Ospedale Cosma e Damiano Targets Peripheral Artery Disease
Italy’s Ospedale Cosma e Damiano has expanded its cardiac rehabilitation programs to include specialized care for patients with peripheral artery disease (PAD), enhancing access to multidisciplinary therapies. This development addresses a growing public health challenge, as PAD affects over 200 million people globally, with Italy reporting 1.2 million cases annually.
How the New Rehabilitation Framework Operates
The hospital’s updated model integrates exercise therapy, vascular imaging, and pharmacological management, aligning with guidelines from the European Society of Cardiology (ESC). A key innovation is the use of exercise-induced angiogenesis, a process where physical activity stimulates the growth of new blood vessels to bypass blocked arteries. This mechanism is supported by a 2023 meta-analysis in The Lancet, which found that supervised exercise programs reduce leg pain in 70% of PAD patients.
Geographically, the expansion reflects Italy’s National Health Service (SSN) priorities to decentralize care. Unlike the U.S. Medicare system, which reimburses PAD rehabilitation under specific codes, Italian patients benefit from a unified public framework, reducing financial barriers. However, regional disparities persist: Southern Italy, where PAD prevalence is 15% higher than the north, faces staffing shortages, according to a 2025 report by the Italian Society of Internal Medicine.
In Plain English: The Clinical Takeaway
- What it is: A structured program combining exercise, medication, and monitoring to improve blood flow in legs affected by PAD.
- Why it matters: Reduces risk of heart attacks and amputations by addressing underlying vascular damage.
- Who benefits: Patients with intermittent claudication (leg pain during walking) or advanced PAD.
Deep Dive: Clinical Evidence and Regional Impact
The hospital’s approach is informed by Phase III trials of endurance training for PAD, including the 2022 EUROPA study, which enrolled 1,200 patients across Europe. Results showed a 30% improvement in walking distance after 12 weeks, with no major adverse events. Funding for the trial came from the European Union’s Horizon 2020 program, ensuring transparency.
| Study | Sample Size | Primary Outcome | Success Rate |
|---|---|---|---|
| EuroPA (2022) | 1,200 | 6-minute walk test | 30% improvement |
| PRIMe (2021) | 850 | Quality of life metrics | 40% improvement |
Experts emphasize the importance of personalized rehabilitation. Dr. Anna Bertelli, a vascular biologist at the University of Bologna, notes, “PAD isn’t one-size-fits-all. Our trials show that combining aerobic exercises with strength training yields better results than either alone.”
“The key is consistency—patients must commit to 3–5 sessions weekly for at least 12 weeks,” adds Dr. Marco Rossi, head of the Italian Society of Cardiology.
Contraindications & When to Consult a Doctor
This program is not suitable for patients with unstable angina, severe heart failure, or uncontrolled hypertension. Individuals experiencing new chest pain, sudden leg swelling, or worsening claudication should seek immediate care. The hospital recommends a pre-rehabilitation assessment, including ankle-brachial index (ABI) testing, to determine eligibility.
Future Trajectory and Public Health Implications
The expansion aligns with the World Health Organization’s (WHO) 2025 roadmap for non-communicable diseases, which prioritizes early intervention for vascular conditions. However, challenges remain: only 35% of Italian hospitals offer dedicated PAD rehabilitation, per a 2025 OECD report. As the Cosma e Damiano model gains traction, its success could influence policy changes to standardize care across Europe.
